Miller Tabak Downgrades Mead Johnson Nutrition (MJN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- S&P 500 and Nasdaq slip as chip rout extends; Netflix slides
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
Deutsche Bank Remains Optimistic on Mead Johnson (MJN) After Q4 Print, Boosts PT
February 1, 2013 11:41 AM ESTDeutsche Bank raised its price target on Mead Johnson Nutrition (NYSE: MJN) from $77 to $81 and affirmed its Buy rating following Q4 results.
The firm comments, "In the face of building pessimism in late 2012 and into 2013, we maintained an optimistic view on... More
Mead Johnson (MJN) Tops Q4 EPS by 4c, Gives FY13 Guidance
January 31, 2013 7:40 AM ESTMead Johnson Nutrition Co. (NYSE: MJN) reported Q4 EPS of $0.72, $0.04 better than the analyst estimate of $0.68. Revenue for the quarter came in at $981.1 million versus the consensus estimate of $953.84 million.
Mead Johnson Nutrition Co. sees FY2013 EPS of $3.22-3.30, versus the consensus of $3.33.... More
